FATE
Fate Therapeutics Inc

6,249
Loading...
Loading...
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
181

Frequently Asked Questions

What is Market Cap of Fate Therapeutics Inc?
What is the 52-week high for Fate Therapeutics Inc?
What is the 52-week low for Fate Therapeutics Inc?
What is Fate Therapeutics Inc stock price today?
What was Fate Therapeutics Inc stock price yesterday?
What is the PE ratio of Fate Therapeutics Inc?
What is the Price-to-Book ratio of Fate Therapeutics Inc?
What is the 50-day moving average of Fate Therapeutics Inc?
How many employess does Fate Therapeutics Inc has?

Latest FATE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.